Search PubMed⌕ Search

Biomedical subjects

R C Armstrong

Publications and source records attributed to R C Armstrong.

53 records · Page 3Linked to original sources

Type 1 astrocytes and oligodendrocyte-type 2 astrocyte glial progenitors migrate toward distinct molecules.

During central nervous system (CNS) development, glial precursors proliferate in subventricular zones and then migrate throughout the CNS to adopt their final destinations and differentiate into various types of mature glial cells. Although several growth factors promoting the proliferation and/or differentiation of glial precursors have been identified, very little is known about the nature of signals that guide glial cell migration in the CNS. Therefore, we have investigated whether polypeptide growth factors and/or extracellular matrix molecules may mediate the migration of two major glial cell types, type 1 astrocytes and oligodendrocyte-type 2 astrocyte (O-2A) progenitor cells. We show that, in a microchemotaxis chamber assay, type 1 astrocytes move toward laminin and complement-derived C5a. Astrocyte migration toward laminin is inhibited by a laminin-specific pentapeptide, YIGSR-NH2. In contrast, O-2A progenitors migrate toward platelet-derived growth factor (PDGF), which also functions as a mitogen for these cells. Using a new method to simultaneously assay migration and DNA synthesis, we also demonstrate that O-2A progenitors can migrate toward PDGF even when DNA replication is inhibited with an antimitotic agent. Thus, migration of different types of glial cells can be induced in vitro by specific signaling molecules, which are present in the developing brain and may stimulate migration of glial cells prior to CNS myelination.

Amino Acid Sequence↗

Histologic response to intradermal Zyderm and Zyplast (glutaraldehyde cross-linked) collagen in humans.

Biopsies were periodically taken over 6 months from sites injected intradermally with purified bovine collagen, Zyderm collagen implant, and a similar collagen, cross-linked with glutaraldehyde, Zyplast implant. The ultimate fate of the implants differed. Zyderm collagen was dispersed among host collagen fibers and gradually lost the appearance of a cohesive implant. By 90 days, the injected material could not be detected and was presumably resorbed, without becoming colonized by host fibroblasts. In contrast, the cross-linked implant remained as distinct foci for 3 to 6 months accompanied by massing of fibroblasts around the periphery. These fibroblasts subsequently invaded the implant and provoked an inflammatory reaction which replaced the implant by new host collagen. The fine collagen bundles in parallel arrays along with many small blood vessels were deposited in the site formerly occupied by the implant. These findings indicate that Zyplast collagen might provide longer-lasting correction of soft tissue defects.

Absorption↗